5-year survival rates for<unk>  cell lung cancer (extensive and limited) range between 3.6% and 32.2% for women, and between 2.2% and 24.5% for men. Relative 5-year survival rate for both sexes has increased from 3.6% in 1975 to 6.7% in 2014.<unk>  is very responsive to chemotherapy and radiotherapy, and in particular, regimens based on platinum-containing agents. However, most people with the disease relapse and median survival remains low. The overall incidence and mortality rates of SCLC in the United States have decreased during the past few decades. Pie chart showing incidence of<unk> -cell lung cancer (shown in red at right), as compared to other lung cancer types, with fractions of smokers versus non-smokers shown for each type. In limited-stage disease, relative 5-year survival rate (both sexes, all races, all ages) is 21.3%; however, women have higher 5-year survival rates, 26.9%, and men have lower survival rates, 21.3%. The prognosis is far grimmer in extensive-stage<unk> -cell lung carcinoma where 5-year relative survival rate (both sexes, all races, all ages) is 2.8%; however, women have higher 5-year survival rates, 3.4%, and men have lower 5-year survival rates, 2.2%. Long-term survival of more than 5 years can be achieved with proper treatment. According to the 17th World Conference on Lung Cancer (WCLC), "patients who received chest radiation and prophylactic cranial irradiation along with a mean of five chemotherapy cycles could achieve a median survival of more than 5 years." In some cases, long-term survival of 10+ years is achieved with chemotherapy and radiation alone. 5-year survival rates The SEER database tracks 5-year relative survival rates based on age, sex, and race and is considered the most accurate source of survival information. This database uses terms "Localized," "Regional," and "Distant" to describe various stages of<unk>  cell lung cancer. 5-year relative survival rate for "both sexes" and "all races" affected by * "Localized"<unk>  cell lung cancer is 28.5%; * "Regional"<unk>  cell lung cancer 14.9%; and for * "Distant"<unk>  cell lung cancer 2.9%. Survival rates by sex Women affected by<unk> -cell lung cancer have higher 5-year survival rates than men. * Localized: Women – 32.2% Men – 24.5% * Regional: Women – 17.0% Men – 12.3% * Distant: Women – 3.6% Men – 2.2% Survival rates by race, sex, age 5-year relative survival statistics are more accurate and, in some cases, higher when specific race and age range are combined with sex and stage at diagnosis. For example, * Black / Ages < = 7.0%. * White / Ages < = 6.1% National Cancer Institute's SEER maintains publicly accessible database for specific survival rates.
Small-cell carcinoma
Adenomatoid tumor
Mucinous carcinoma
Sarcomatoid carcinoma
Spindle cell carcinoma
Signet ring cell carcinoma
Adenosarcoma
Adenocarcinoma